Evidence for the involvement of VAR2CSA in pregnancy-associated malaria

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. / Salanti, Ali; Dahlbäck, Madeleine; Turner, Louise; Nielsen, Morten A; Barfod, Lea; Magistrado, Pamela; Jensen, Anja T R; Lavstsen, Thomas; Ofori, Michael F; Marsh, Kevin; Hviid, Lars; Theander, Thor G.

I: Journal of Experimental Medicine, Bind 200, Nr. 9, 2004, s. 1197-203.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Salanti, A, Dahlbäck, M, Turner, L, Nielsen, MA, Barfod, L, Magistrado, P, Jensen, ATR, Lavstsen, T, Ofori, MF, Marsh, K, Hviid, L & Theander, TG 2004, 'Evidence for the involvement of VAR2CSA in pregnancy-associated malaria', Journal of Experimental Medicine, bind 200, nr. 9, s. 1197-203. https://doi.org/10.1084/jem.20041579

APA

Salanti, A., Dahlbäck, M., Turner, L., Nielsen, M. A., Barfod, L., Magistrado, P., Jensen, A. T. R., Lavstsen, T., Ofori, M. F., Marsh, K., Hviid, L., & Theander, T. G. (2004). Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. Journal of Experimental Medicine, 200(9), 1197-203. https://doi.org/10.1084/jem.20041579

Vancouver

Salanti A, Dahlbäck M, Turner L, Nielsen MA, Barfod L, Magistrado P o.a. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. Journal of Experimental Medicine. 2004;200(9):1197-203. https://doi.org/10.1084/jem.20041579

Author

Salanti, Ali ; Dahlbäck, Madeleine ; Turner, Louise ; Nielsen, Morten A ; Barfod, Lea ; Magistrado, Pamela ; Jensen, Anja T R ; Lavstsen, Thomas ; Ofori, Michael F ; Marsh, Kevin ; Hviid, Lars ; Theander, Thor G. / Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. I: Journal of Experimental Medicine. 2004 ; Bind 200, Nr. 9. s. 1197-203.

Bibtex

@article{7d142a40a03411dd86a6000ea68e967b,
title = "Evidence for the involvement of VAR2CSA in pregnancy-associated malaria",
abstract = "In Plasmodium falciparum-endemic areas, pregnancy-associated malaria (PAM) is an important health problem. The condition is precipitated by accumulation of parasite-infected erythrocytes (IEs) in the placenta, and this process is mediated by parasite-encoded variant surface antigens (VSA) binding to chondroitin sulfate A (CSA). Parasites causing PAM express unique VSA types, VSAPAM, which can be serologically classified as sex specific and parity dependent. It is sex specific because men from malaria-endemic areas do not develop VSAPAM antibodies; it is parity dependent because women acquire anti-VSAPAM immunoglobulin (Ig) G as a function of parity. Previously, it was shown that transcription of var2csa is up-regulated in placental parasites and parasites selected for CSA binding. Here, we show the following: (a) that VAR2CSA is expressed on the surface of CSA-selected IEs; (b) that VAR2CSA is recognized by endemic plasma in a sex-specific and parity-dependent manner; (c) that high anti-VAR2CSA IgG levels can be found in pregnant women from both West and East Africa; and (d) that women with high plasma levels of anti-VAR2CSA IgG give birth to markedly heavier babies and have a much lower risk of delivering low birth weight children than women with low levels.",
author = "Ali Salanti and Madeleine Dahlb{\"a}ck and Louise Turner and Nielsen, {Morten A} and Lea Barfod and Pamela Magistrado and Jensen, {Anja T R} and Thomas Lavstsen and Ofori, {Michael F} and Kevin Marsh and Lars Hviid and Theander, {Thor G}",
note = "Keywords: Africa; Birth Weight; Chondroitin Sulfates; DNA Primers; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Male; Microscopy, Confocal; Placenta; Pregnancy; Protozoan Proteins; Recombinant Proteins; Sex Factors",
year = "2004",
doi = "10.1084/jem.20041579",
language = "English",
volume = "200",
pages = "1197--203",
journal = "The Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Evidence for the involvement of VAR2CSA in pregnancy-associated malaria

AU - Salanti, Ali

AU - Dahlbäck, Madeleine

AU - Turner, Louise

AU - Nielsen, Morten A

AU - Barfod, Lea

AU - Magistrado, Pamela

AU - Jensen, Anja T R

AU - Lavstsen, Thomas

AU - Ofori, Michael F

AU - Marsh, Kevin

AU - Hviid, Lars

AU - Theander, Thor G

N1 - Keywords: Africa; Birth Weight; Chondroitin Sulfates; DNA Primers; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Female; Humans; Immunoglobulin G; Malaria, Falciparum; Male; Microscopy, Confocal; Placenta; Pregnancy; Protozoan Proteins; Recombinant Proteins; Sex Factors

PY - 2004

Y1 - 2004

N2 - In Plasmodium falciparum-endemic areas, pregnancy-associated malaria (PAM) is an important health problem. The condition is precipitated by accumulation of parasite-infected erythrocytes (IEs) in the placenta, and this process is mediated by parasite-encoded variant surface antigens (VSA) binding to chondroitin sulfate A (CSA). Parasites causing PAM express unique VSA types, VSAPAM, which can be serologically classified as sex specific and parity dependent. It is sex specific because men from malaria-endemic areas do not develop VSAPAM antibodies; it is parity dependent because women acquire anti-VSAPAM immunoglobulin (Ig) G as a function of parity. Previously, it was shown that transcription of var2csa is up-regulated in placental parasites and parasites selected for CSA binding. Here, we show the following: (a) that VAR2CSA is expressed on the surface of CSA-selected IEs; (b) that VAR2CSA is recognized by endemic plasma in a sex-specific and parity-dependent manner; (c) that high anti-VAR2CSA IgG levels can be found in pregnant women from both West and East Africa; and (d) that women with high plasma levels of anti-VAR2CSA IgG give birth to markedly heavier babies and have a much lower risk of delivering low birth weight children than women with low levels.

AB - In Plasmodium falciparum-endemic areas, pregnancy-associated malaria (PAM) is an important health problem. The condition is precipitated by accumulation of parasite-infected erythrocytes (IEs) in the placenta, and this process is mediated by parasite-encoded variant surface antigens (VSA) binding to chondroitin sulfate A (CSA). Parasites causing PAM express unique VSA types, VSAPAM, which can be serologically classified as sex specific and parity dependent. It is sex specific because men from malaria-endemic areas do not develop VSAPAM antibodies; it is parity dependent because women acquire anti-VSAPAM immunoglobulin (Ig) G as a function of parity. Previously, it was shown that transcription of var2csa is up-regulated in placental parasites and parasites selected for CSA binding. Here, we show the following: (a) that VAR2CSA is expressed on the surface of CSA-selected IEs; (b) that VAR2CSA is recognized by endemic plasma in a sex-specific and parity-dependent manner; (c) that high anti-VAR2CSA IgG levels can be found in pregnant women from both West and East Africa; and (d) that women with high plasma levels of anti-VAR2CSA IgG give birth to markedly heavier babies and have a much lower risk of delivering low birth weight children than women with low levels.

U2 - 10.1084/jem.20041579

DO - 10.1084/jem.20041579

M3 - Journal article

C2 - 15520249

VL - 200

SP - 1197

EP - 1203

JO - The Journal of Experimental Medicine

JF - The Journal of Experimental Medicine

SN - 0022-1007

IS - 9

ER -

ID: 6746921